Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06909292 · ClinicalTrials.gov registry record
Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1
A clinical trial of Sacroiliac Joint Dysfunction, sponsored by Nevro.
- Recruiting
- Registry status
- 180
- Enrollment target
- 5
- Study locations
NCT06909292: Recruiting study of Sacroiliac Joint Dysfunction, sponsored by Nevro.
NCT06909292 is a study of Sacroiliac Joint Dysfunction that is actively recruiting participants, run by Nevro. The registered enrollment target is 180 participants, above the 153-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (18% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06909292, a study of Sacroiliac Joint Dysfunction, is actively recruiting participants, sponsored by Nevro.
- RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this observational study is to learn if Nevro1 Sacroiliac Transfixing and Fusion System can treat sacroiliac joint dysfunction in males or females over 21. The main questions it aims to answer is what percentage of patients have clinically important pain relief with no adverse events, and what proportion of patients have fusion of the sacroiliac joint at 1 year and 2 years.
Primary Outcome
The proportion of patient meeting the following criteria: * NRS score for SIJ pain reduced by at least 2 points from baseline. * Absence of implant-related serious adverse events (SAEs). * Absence of neurologic worsening related to the lumbosacral nerve roots. * Absence of reoperation (removal, revision reoperation or supplemental fixation) for SIJ pain.
Conditions Studied
Interventions
- DEVICE Sacroiliac Joint transfixing and fusion system (Nevro1)
Study Locations (5)
Texas
- Advanced Spine and Pain Specialists - Spring
- Procura Pain and Spine - The Woodlands
California
- AIRS Clinic - Lodi
Michigan
- Michigan Orthopaedic Surgeons - Southfield
North Carolina
- Carolinas Pain Institute - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-04-03 |
| Est. Completion | 2027-06 |
What NCT06909292 shows while recruiting
NCT06909292 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 153-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Sacroiliac Joint Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Sacroiliac Joint transfixing and fusion system (Nevro1) is the first listed.
NCT06909292 lists 5 locations in 4 states (Texas, California, Michigan).
Frequently Asked Questions
What is clinical trial NCT06909292 about?
NCT06909292 is a clinical study titled "Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1". The goal of this observational study is to learn if Nevro1 Sacroiliac Transfixing and Fusion System can treat sacroiliac joint dysfunction in males or females over 21. The main questions it aims to answer is what percentage of patients have clinically important pain relief with no adverse events, an...
What is the current status of trial NCT06909292?
This trial is currently recruiting. The enrollment target is 180 participants. The study started on 2025-04-03. Estimated completion is 2027-06.
What conditions does trial NCT06909292 study?
This clinical trial studies the following conditions: Sacroiliac Joint Dysfunction.
What interventions are being tested in trial NCT06909292?
The interventions under investigation include: Sacroiliac Joint transfixing and fusion system (Nevro1) (DEVICE).
Who is sponsoring clinical trial NCT06909292?
This trial is sponsored by Nevro, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06909292 being conducted?
This trial has 5 study locations across California, Michigan, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliac Joint Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI